Newsletter Signup | Join Community
Stay Current With Bladder Cancer Treatment Advances & Connect with Others
FDA Approves PD-1 Checkpoint Inhibitor Opdivo for Treatment of Bladder Cancer
Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer
Dr. Michael O’Donnell, MD, Director of Urologic Oncology University of Iowa answers questions about bladder cancer.
IDO inhibitor epacadostat and the anti-PD-1 drug Keytruda (pembrolizumab) promising in bladder cancer.
Vicinium promising for treatment of early stage and superficial bladder cancers.